Edition:
United States

Aurinia Pharmaceuticals Inc (AUP.TO)

AUP.TO on Toronto Stock Exchange

9.11CAD
3:59pm EST
Change (% chg)

$-0.15 (-1.62%)
Prev Close
$9.26
Open
$9.31
Day's High
$9.43
Day's Low
$9.00
Volume
112,878
Avg. Vol
60,291
52-wk High
$10.47
52-wk Low
$5.98

Chart for

About

Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis (LN). It is focused on the development of its lead... (more)

Overall

Beta: 3.00
Market Cap(Mil.): $622.31
Shares Outstanding(Mil.): 85.32
Dividend: --
Yield (%): --

Financials

  AUP.TO Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -0.83 -- --
ROI: -30.75 0.60 13.80
ROE: -36.08 -2.18 15.29

Earnings vs. Estimates